Neurosurgery
Consensus Recommendations: Early management of patients with aneurysmal subarachnoid hemorrhage in a hospital with neurosurgical/neuroendovascular facilities.
22 Jun, 2022 | 11:25h | UTC
Summary of the new 2022 AHA/ASA Guideline on intracerebral hemorrhage.
21 Jun, 2022 | 10:54h | UTCIntracerebral Hemorrhage 2022 Guideline Update – emDocs
Original Guideline: 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association – Stroke
Top Things to Know: 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage – American Heart Association
News Release: New guideline refines care for brain bleeds: compression socks, some meds not effective – American Heart Association
Acute shortage of iodinated contrast media: implications and guidance for neurovascular imaging and intervention.
20 Jun, 2022 | 01:20h | UTCRelated Guidance:
Short-, Mid-, and Long-Term Strategies to Manage the Shortage of Iohexol – Radiology
Related Study:
Comparison of Strategies to Conserve Iodinated Intravascular Contrast Media for Computed Tomography During a Shortage – JAMA (free for a limited period) AND News Release: Amid Global Shortage, Study Shows How to Cut Contrast Dye Use 83% – University of California, San Francisco (UCSF)
Interventions in acute intracranial surgery: an evidence-based perspective.
16 Jun, 2022 | 10:59h | UTCInterventions in Acute Intracranial Surgery: An Evidence-Based Perspective – World Neurosurgery
Consensus Recommendation: Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis.
15 Jun, 2022 | 10:56h | UTC
Study Commentary: Dexamethasone should not be given to people with a chronic subdural hematoma.
15 Jun, 2022 | 10:28h | UTCDexamethasone should not be given to people with a chronic subdural haematoma
Original Study: Trial of Dexamethasone for Chronic Subdural Hematoma – New England Journal of Medicine
BSH guideline for the hematological management of major hemorrhage.
13 Jun, 2022 | 10:53h | UTC
Long-term follow-up of RCT: Decompressive craniectomy vs. standard medical care in patients with traumatic intracranial hypertension.
10 Jun, 2022 | 12:45h | UTCEvaluation of Outcomes Among Patients With Traumatic Intracranial Hypertension Treated With Decompressive Craniectomy vs Standard Medical Care at 24 Months: A Secondary Analysis of the RESCUEicp Randomized Clinical Trial – JAMA Neurology (free for a limited period)
Original Study: Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension – New England Journal of Medicine
Related:
The Current Status of Decompressive Craniectomy in Traumatic Brain Injury – Current Trauma Reports
Commentary on Twitter
In this study, at 24 months, patients with posttraumatic refractory intracranial hypertension managed with a decompressive craniectomy had a sustained mortality reduction and higher rates of vegetative state, severe disability, and moderate disability. https://t.co/I8GqG885jh
— JAMA Neurology (@JAMANeuro) June 9, 2022
Guidelines for clothing in the operating theatre.
30 May, 2022 | 11:52h | UTCGuidelines for clothing in the operating theatre, 2021 – Anaesthesia Critical Care & Pain Medicine
M-A: Stereotactic radiosurgery vs. whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer.
30 May, 2022 | 10:41h | UTCStereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis – The Lancet Oncology (link to abstract – $ for full-text)
M-A: Surgical timing in patients with infective endocarditis and with intracranial hemorrhage.
27 May, 2022 | 11:25h | UTC
Commentary from the author on Twitter
Check out the results of our meta-analysis regarding operation timing in endocarditis patients with intracranial hemorrhage.
An interesting highlight is the evident immortal-time bias present in most studies. See more: https://t.co/6YskZPIXWB@HrisKirov @MahmDiab @ToDoenst pic.twitter.com/HvcbjTQAjT
— Tulio Caldonazo, MD (@TulioCaldonazo) May 17, 2022
Under a Creative Commons Attribution‐Noncommercial License
Guidelines on the management of lumbar spinal stenosis.
26 May, 2022 | 10:44h | UTC
Cross-sectional study: assessment of perioperative outcomes among surgeons who operated the night before.
24 May, 2022 | 08:17h | UTCAssessment of Perioperative Outcomes Among Surgeons Who Operated the Night Before – JAMA Internal Medicine (free for a limited period)
Invited Commentary: Are Surgeons Really More Resilient Than Athletes? The Trade-off Between Surgeon Outcomes and Surgeon Well-being – JAMA Internal Medicine (free for a limited period)
Author Interview: Assessment of Perioperative Outcomes Among Surgeons Who Operated the Night Before
Commentary on Twitter
This cross-sectional study found that operating overnight does not appear to be associated with worse outcomes when the attending surgeon continues to operate the next day. https://t.co/ahLoKav6HT
— JAMA Internal Medicine (@JAMAInternalMed) May 23, 2022
Management of moderate to severe traumatic brain injury: an update for the intensivist.
23 May, 2022 | 01:42h | UTC
Commentary on Twitter
Management of moderate to severe TBI
⏳ first hours: initial #resuscitation targets
?? in #ICU, ⬇️ secondary insults after trauma: ICP, CPP, hemodynamics
? multimodality monitoring targets & management
? extracranial complications
? long‐term outcomehttps://t.co/do6a3Fe5vs pic.twitter.com/uGxxfI5hOZ— Intensive Care Medicine (@yourICM) May 21, 2022
Cohort Study: Effect of awake craniotomy in glioblastoma in eloquent areas.
23 May, 2022 | 00:40h | UTCEffect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study – the Lancet Oncology (link to abstract – $ for full-text)
Commentary: Neurologic and Survival Outcomes After Awake Craniotomy for Glioblastoma – The ASCO Post
Commentary on Twitter
In matched cohort of patients with glioblastoma, awake craniotomy resulted in fewer neurological deficits at 3 mo and 6 mo post-surgery than asleep resection, and longer mOS (17.0 mo versus 14.0 mo; P =0.0005), and mPFS (9.0 mo versus 7.3 mo; P = 0.006) https://t.co/S1fdRTxYDg
— NatureRevClinOncol (@NatRevClinOncol) May 19, 2022
AHA/ASA Guideline: Management of patients with spontaneous intracerebral hemorrhage.
18 May, 2022 | 12:01h | UTCTop Things to Know: 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage – American Heart Association
News Release: New guideline refines care for brain bleeds: compression socks, some meds not effective – American Heart Association
Commentary on Twitter
Released today: Guidelines for treating spontaneous ICH
Includes:
➡️ Acute reversal of anticoagulation after ICH
➡️Updates to common interventions
➡️Minimally invasive surgical recommendations✍️ @SMGreenbergNeur @WendyZiai
? @StrokeAHA_ASA https://t.co/6YQ2TLy3NW pic.twitter.com/y93qQGCmfV
— AHA Science (@AHAScience) May 17, 2022
Review: Radiological assessment of chronic subdural hematomas.
16 May, 2022 | 01:17h | UTCRadiological Assessment of Chronic Subdural Hematomas – Korean Journal of Neurotrauma
Review: Steroid use in patients with acute spinal cord injury and guideline update.
16 May, 2022 | 01:22h | UTC
ASTRO Guideline: Radiation therapy for brain metastases.
12 May, 2022 | 10:11h | UTCNews Release: ASTRO issues clinical guideline on radiation therapy for brain metastases – American Society for Radiation Oncology
Commentary on Twitter
ASTRO has released a guideline on #RadiationTherapy for brain metastases, which updates the original 2012 guideline. The publication in #PracticalRO includes treatment algorithms for limited & extensive brain metastases. Read here: https://t.co/5QRI0XqWHx #RadOnc pic.twitter.com/oNj2nzAKdm
— ASTRO (@ASTRO_org) May 10, 2022
Review: Diagnosis and management of lumbar spinal stenosis.
4 May, 2022 | 10:45h | UTCDiagnosis and Management of Lumbar Spinal Stenosis: A Review – JAMA (free for a limited period)
Audio Clinical Review: Lumbar Spinal Stenosis: A Review – JAMA
M-A: The clinical effect and safety of new preoperative fasting time guidelines for elective surgery.
12 Apr, 2022 | 09:51h | UTCRelated:
Does my hospitalized patient need an NPO-after-midnight order preoperatively?
Pro-Con Debate: 1- vs 2-Hour Fast for Clear Liquids Before Anesthesia in Children.
M-A: Prophylactic therapies for morbidity and mortality after aneurysmal subarachnoid hemorrhage.
11 Apr, 2022 | 00:52h | UTCProphylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials – Stroke (link to abstract – $ for full-text)
Commentary on Twitter
Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials #stroke #AHAJournals https://t.co/GkM5GlFBd7 pic.twitter.com/6ipIaUK5KX
— Stroke AHA/ASA (@StrokeAHA_ASA) April 8, 2022
State of the Art Review: Prognostication and shared decision making in neurocritical care.
8 Apr, 2022 | 10:53h | UTCPrognostication and shared decision making in neurocritical care – The BMJ
Commentary on Twitter
It's out TODAY: Thank you @bmj_latest for this opportunity as an invited 'State of the Art Review'? on such an important topic‼️ Great job @K_Goostrey ??. Proud of this product: ?Prognostication and Shared Decision Making in #NCC https://t.co/VeFUlRe0xG @UMassChanNeuro
— S Muehlschlegel MD MPH, FNCS, FCCM, FAAN (@SMuehlschMD) April 7, 2022
RCT: Effects of clazosentan on cerebral vasospasm–related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage.
6 Apr, 2022 | 10:47h | UTC
Study finds no increased risk of brain tumors for mobile phone users.
1 Apr, 2022 | 10:04h | UTCNews Release: No increased risk of brain tumours for mobile phone users, new study finds – University of Oxford
Original Study: Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study – JNCI: Journal of the National Cancer Institute